Legal Opinion

In re Galena Biopharma, Inc.

District Court, D. New Jersey

Decided August 21, 2018No. 2:17-cv-929-KM-JBCPublishedCited by 7 opinions

1Opinion of the Court

MCNULTY, U.S.D.J.

*381The plaintiffs have filed a class-action complaint alleging securities fraud against Galena Biopharma, Inc. ("Galena") and several of its officers or key employees. The complaint alleges that the defendants failed to make appropriate disclosures under Item 303 of Regulation S-K and therefore committed securities fraud. Now before the court are defendants' motions to dismiss the complaint. For the reasons expressed herein, those motions are granted without prejudice to the submission of a second amended complaint within 30 days.

I. BACKGROUND1

A. Relevant Parties

Plaintiffs,…

2Cases cited24 opinions

  1. Warth v. SeldinSupreme Court of the United States · 1975
  2. Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
  3. Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
  4. Basic Inc. v. LevinsonSupreme Court of the United States · 1988
  5. TSC Industries, Inc. v. Northway, Inc.Supreme Court of the United States · 1976

19 more not listed; retrieve them via the Exa API.

3Cited by7 opinions

  1. CARMIGNAC GESTION, S.A. v. PERRIGO COMPANY PLCDistrict Court, D. New Jersey · 2019
  2. City of Taylor General Employees Retirement System v. Astec Industries, Inc.District Court, E.D. Tennessee · 2021
  3. FIRST MANHATTAN CO. v. PAPADistrict Court, D. New Jersey · 2019
  4. MANNING & NAPIER ADVISORS, LLC v. PERRIGO COMPANY PLCDistrict Court, D. New Jersey · 2019
  5. NATIONWIDE MUTUAL FUNDS v. PERRIGO COMPANY PLCDistrict Court, D. New Jersey · 2019

2 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API